《港樓》峻譽-渣甸山獲內地首置買家一客兩食 套現共4,592.5萬元
中信股份(00267.HK)旗下中信泰富地產的大坑道豪宅項目峻譽-渣甸山再錄2宗成交。該2宗成交由同一組客戶購入,單位為第二座15樓A及E單位。合共套現4,592.51萬元。
其中,第二座15樓A單位以2,562.51萬元招標售出,屬兩房一套間隔,實用面積687平方呎,呎價37,300元,另外,第二座15樓E單位以2,030萬元連一個停車位招標售出,單位採兩房間隔,實用面積439平方呎,呎價46,241元。
家為內地首次來港置業人士,經深入了解香港不同地段豪宅項目後,決定入標,最終成功購入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.